Mizuho Forecasts Strong Price Appreciation for UnitedHealth Group (NYSE:UNH) Stock

Key Points

• Mizuho has raised its target price for UnitedHealth Group's stock from $300.00 to $430.00, indicating a potential upside of 14.68% based on the current price.
• A total of 16 analysts have given the stock a Buy rating, while the consensus price target stands at $383.09.
• UnitedHealth Group's recent earnings report showed a 12.9% year-over-year revenue increase, though EPS fell short of analysts' estimates.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its target price raised by Mizuho from $300.00 to $430.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has an "outperform" rating on the healthcare conglomerate's stock. Mizuho's price objective suggests a potential upside of 14.68% from the company's current price.

A number of other research analysts have also issued reports on UNH. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an "overweight" rating in a research note on Tuesday. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research report on Friday, September 12th. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Finally, KeyCorp increased their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a report on Wednesday. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $383.09.

UnitedHealth Group Stock Up 1.4%

Shares of NYSE UNH opened at $374.97 on Thursday. The firm has a market cap of $339.60 billion, a price-to-earnings ratio of 16.25, a PEG ratio of 2.35 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $630.73. The business's 50 day moving average is $313.51 and its two-hundred day moving average is $352.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC increased its stake in UnitedHealth Group by 3.3% in the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock worth $6,624,411,000 after purchasing an additional 675,075 shares during the period. Norges Bank purchased a new position in UnitedHealth Group in the 2nd quarter worth approximately $3,837,207,000. Finally, Dodge & Cox grew its position in shares of UnitedHealth Group by 117.7% in the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after buying an additional 4,730,192 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.